Novartis sets its foot in Singapore by investing $256 Million in Antibody Plant Expansion and plans to hire 100 new employees. Novartis, one of the largest pharmaceutical companies, is expanding its reach worldwide to provide healthcare and jobs to the people. After Novo Nordisk and Roche, Novartis is Europe’s third-largest pharma company. With more than 76,000 employees around the globe in the year 2023, Novartis is supporting more people by offering jobs in Singapore.  While working in the therapeutic areas, namely Cardiovascular, Renal, metabolic diseases, Neuroscience, Oncology and Im ..read more

As per the reports, the U.S. Food and Drug Administration (FDA) issued a warning letter to Cardinal Health (CAH.N) after an inspection at its Illinois facility. The agency identified the company’s involvement in marketing and distributing the unapproved medical devices sourced from a Chinese manufacturer. Following the ongoing investigations into reports of quality issues, including leaks and breakages, associated with certain syringes manufactured in China, the FDA had previously advised against using select China-made syringes. This guidance was expanded last month. Upon inspection, the FDA ..read more

Researchers from the Johns Hopkins Kimmel Cancer Center and its Convergence Institute reveal promising results of personalised vaccine for liver cancer. Liver cancer is one of the life-threatening illnesses and fastest-growing cancer types in the United States. Since there are no symptoms in the early stages of cancer, it is often diagnosed late when cancer has majorly affected the healthy cells in the liver. Its symptoms are similar to Intrahepatic cholangiocarcinoma (IHC), like a lump below your rib cage or pain near your right shoulder, jaundice, unexplained weight loss, nausea, loss of app ..read more

Thermo Fisher will lay off its 74 employees by 31st May 2024 at its Plasmid Manufacturing Facility in California.  Thermo Fisher Scientific is a global leader in scientific solutions and boasts an impressive annual revenue of over $40 billion. Its extensive portfolio encompasses a spectrum of cutting-edge technologies and services seamlessly integrated under renowned brands like Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. This combination offers its customers unparalleled access to innovative solutions, streamlined procuremen ..read more

Pharma Utility grabs the opportunity to showcase its latest offering to the pharma industry by participating in the PharmaLabChem Expo 2024. The event is scheduled from May 9th to May 11th, 2024, at the Hindustan Antibiotic Exhibition Ground, Pune.  Since its inception in 2007, Pharma Utility has consistently set the standard for excellence in B2B platforms by providing comprehensive coverage of the latest news, unique stories, inspiring interviews, and in-depth features and analysis. Pharma Utility has become the preferred choice for professionals seeking valuable information and innovat ..read more

In a surprising turn of events, Pharma Utility, the esteemed publisher of pharmaceutical insights, was recently acquired by a global entity, signaling a potential shift in the landscape of industry media. Since its inception in 2007, Pharma Utility has offered premium content to its B2B customers in the pharma sector. With its unique blend of news stories, interviews, features, and analysis, Pharma Utility has helped its customers stay ahead of the curve in an ever-evolving industry. However, with this acquisition, we hear the whispers of change echoing through the corridors of the pharmaceut ..read more

The most expensive and challenging process that has been existing in the whole world is none other than the discovery of new drugs! It encompasses comprehensive timeframes as well as exceptional costs, which have definitely focused on the requirement for reform in this particular field. Although there have been prior attempts to accelerate the procedure of  drug discovery utilizing computational techniques, advancements have been constrained. Artificial intelligence (AI) has emerged as a promising innovation poised to transform drug discovery and development! It enables the discovery of i ..read more

As per the reports, the hospitals in the small cities of South Korea are grappling with a pronounced shortage of physicians. This problem has been further intensified by an ongoing nationwide strike of trainee doctors, which is now in its third month. Doctors are protesting against the proposed measures to address the shortage of doctors by increasing medical school admissions. While its capital, Seoul, boasts about the prestigious medical facilities, the shortage of doctors in smaller urban centers is anticipated to worsen as the population aging accelerates, alongside its plummeting birthrat ..read more

Despite the acquisition of the three Catalent sites by Novo Nordisk, Catalent is implementing its internal restructuring initiative unveiled in 2023 In the face of a multi-billion-dollar acquisition offer from Novo Holdings, the contract manufacturer Catalent remains persistent with its internal restructuring initiative unveiled last year. Moreover, the company is also contemplating workforce adjustments. This shall affect over a hundred employees at its manufacturing and filling facility in Bloomington, Indiana. The reports show approximately 130 impending staff reductions at the mentioned si ..read more

Boehringer Ingelheim and Ochre Bio have come together to develop and discover innovative regenerative therapies to treat CLD. Image from FreePik Chronic liver disease (CLD) is a progressive deterioration of liver functions for more than six months, including synthesizing clotting factors and other proteins, detoxifying harmful metabolism products, and bile excretion. Nearly one million population is affected by CLD and associated cirrhosis annually. As CLD progresses, the liver’s intrinsic regenerative capacity diminishes, resulting in severe complications such as liver failure or cancer. It ..read more